Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risankizumab-induced red face: a unique presentation.
Roccuzzo G, Giordano S, Bongiovanni E, Giunipero DI Corteranzo I, Cavaliere G, Mastorino L, Quaglino P, Ribero S. Roccuzzo G, et al. Among authors: mastorino l. Ital J Dermatol Venerol. 2024 Jun;159(3):366-367. doi: 10.23736/S2784-8671.24.07828-9. Ital J Dermatol Venerol. 2024. PMID: 38808463 No abstract available.
Effectiveness of biological therapy in reducing psoriasis-related cardiovascular risk.
Boskovic S, Borriello S, D'Ascenzo F, Sciamarrelli N, Rosset F, Mastorino L, Paolo D, Bocchino PP, De Filippo O, Ribero S, De Ferrari G, Quaglino P. Boskovic S, et al. Among authors: mastorino l. Expert Opin Biol Ther. 2024 Apr;24(4):217-219. doi: 10.1080/14712598.2024.2337242. Epub 2024 Apr 1. Expert Opin Biol Ther. 2024. PMID: 38557408 No abstract available.
Dramatic progression of multifocal primary cutaneous anaplastic large-cell lymphoma.
Avallone G, Leo F, Astrua C, Mastorino L, Parente R, Grassi M, Fabrizio R, Ferraris A, Quaglino P, Ribero S. Avallone G, et al. Among authors: mastorino l. Ital J Dermatol Venerol. 2024 Apr;159(2):215-216. doi: 10.23736/S2784-8671.24.07852-6. Epub 2024 Mar 4. Ital J Dermatol Venerol. 2024. PMID: 38436616 No abstract available.
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series.
Gori N, Ippoliti E, Ferrucci SM, Balato A, Ortoncelli M, Maurelli M, Galluzzo M, Munera Campos M, Seremet T, Di Nardo L, Antonelli F, Coscarella G, Conrad C, Carrascosa JM, Bianchi L, Argenziano G, Ribero S, Girolomoni G, Marzano AV, Chiricozzi A, Peris K; MEDaCoTRA Study Group. Gori N, et al. J Eur Acad Dermatol Venereol. 2024 Feb 29. doi: 10.1111/jdv.19929. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38421043 No abstract available.
Safety of dupilumab in patients with cancer.
Macagno N, Mastorino L, Siliquini N, Santaniello U, Gelato F, Cavaliere G, Ortoncelli M, Ribero S, Quaglino P. Macagno N, et al. Among authors: mastorino l. J Eur Acad Dermatol Venereol. 2024 Feb 19. doi: 10.1111/jdv.19873. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38372448 No abstract available.
Secondary laryngeal and pulmonary syphilis: A case report.
Borriello S, Delmonte S, Bisciari T, Mastorino L, Ribero S, Quaglino P. Borriello S, et al. Among authors: mastorino l. J Eur Acad Dermatol Venereol. 2024 Feb 19. doi: 10.1111/jdv.19835. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38372430 No abstract available.
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study.
Avallone G, Cavallo F, Tancredi A, Maronese CA, Bertello M, Fraghì A, Conforti C, Calabrese G, Di Nicola MR, Oddenino GA, Gargiulo L, Gori N, Loi C, Romita P, Piras V, Bonzano L, Tolino E, Paolino G, Napolitano M, Patruno C, Nettis E, Ferreli C, Roccuzzo G, Marozio L, Silvio M, Russo F, Bettolini L, Gallo R, Mercuri SR, Mastorino L, Rossi M, Zalaudek I, Argenziano G, Trave I, Costanzo A, Chiricozzi A, Gurioli C, Foti C, Potenza C, Ferrucci SM, Balato A, Parodi A, Marzano AV, Ortoncelli M, Ribero S, Quaglino P. Avallone G, et al. Among authors: mastorino l. J Eur Acad Dermatol Venereol. 2024 Jan 29. doi: 10.1111/jdv.19794. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38284131
94 results